These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 8367952)

  • 1. [Thrombolytic therapy in acute myocardial infarct and pulmonary artery thromboembolism].
    Iakovlev VB; Gospodarenko AL; Makarenko AS
    Voen Med Zh; 1993 Jun; (6):45-7. PubMed ID: 8367952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
    Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinolytic therapy of patients with pulmonary artery thromboembolism by tissue plasminogen activator and streptokinase preparations].
    Ardashev VN; Sokolianskiĭ NV; Bystrov VV
    Klin Med (Mosk); 2000; 78(12):28-30. PubMed ID: 11210347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
    Ben-Chitrit S; Korzets Z; Hershkovitz R; Bernheim J; Schneider M; Bernheim J
    Nephrol Dial Transplant; 1994; 9(4):428-30. PubMed ID: 8084460
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolytic therapy for coronary occlusion.
    Thompson PL
    Med J Aust; 1992 Jul; 157(2):75-7. PubMed ID: 1630392
    [No Abstract]   [Full Text] [Related]  

  • 8. [Streptodecase-2 in the treatment of acute myocardial infarct, unstable stenocardia, thromboembolism and thrombosis].
    Butorov VN; Repinskaia NP; Demidova AV; Sysoeva NA; Kirichenko AA
    Ter Arkh; 1990; 62(8):21-6. PubMed ID: 2274864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy for myocardial infarction.
    Guerci AD
    Md Med J; 1990 Apr; 39(4):377-81. PubMed ID: 2110282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation.
    Chong BH
    Aust Fam Physician; 1996 Jan; 25(1):74-8. PubMed ID: 8607780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic thrombolytic treatment in myocardial infarct].
    Davi R; Copello F; Pareti G; Freggiaro V; Morelloni S; Corazza M; Fasciolo L; Allegri M
    Clin Ter; 1990 Aug 15-31; 134(3-4):223-35. PubMed ID: 2147625
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary hemorrhage after thrombolysis in acute myocardial infarct].
    Rodríguez Blanco VM; Barriales Alvarez V; Morís de la Tassa C
    An Med Interna; 1997 Apr; 14(4):209. PubMed ID: 9181820
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress on thrombolytic treatment].
    Kazama M
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):885-90. PubMed ID: 1919203
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
    Kandzari DE; Granger CB; Simoons ML; White HD; Simes J; Mahaffey KW; Gore J; Weaver WD; Longstreth WT; Stebbins A; Lee KL; Califf RM; Topol EJ;
    Am J Cardiol; 2004 Feb; 93(4):458-61. PubMed ID: 14969623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy: Current status.
    Fratantoni JC; Ness P; Simon TL
    N Engl J Med; 1975 Nov; 293(21):1073-8. PubMed ID: 1178024
    [No Abstract]   [Full Text] [Related]  

  • 16. [The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage].
    Staroverov II; Dundua DP; Plotnikov AN; Pomerantsev EV; Bliumental' AA; Puchkov AT; Ovasapian IuA; Serov VP; Ruda MIa
    Kardiologiia; 1993; 33(3):28-32. PubMed ID: 8377336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue plasminogen activator (rt-PA) in patients with acute myocardial infarction].
    Sandar Núñez D; Ruiz Santana S; García Jiménez A; Castro Mao M
    Med Clin (Barc); 1997 Mar; 108(8):318. PubMed ID: 9121219
    [No Abstract]   [Full Text] [Related]  

  • 18. Stroke associated with thrombolytic therapy for acute myocardial infarction.
    Sloan MA
    Heart Dis Stroke; 1992; 1(5):287-94. PubMed ID: 1344119
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.